Nobori Dual Antiplatelet Therapy as Appropriate Duration

计划入组 3,773 人 · 首次发布于 2012 年 1 月 23 日

Dual Antiplatelet Therapy Adherence With Reminder App Usage

计划入组 9 人 · 首次发布于 2021 年 10 月 7 日

Reversibility of Dual Antiplatelet Therapy by Platelets

计划入组 6 人 · 首次发布于 2010 年 11 月 25 日

Policosanol

Rx

CRO-67

Anti-CD34 mab-sirolimus (OrbusNeich)

METABOLIC THERAPY, INC.

United States

Everads Therapy Ltd.

Israel

ATI Physical Therapy

United States

TACSI Trial Challenges Dual Antiplatelet Therapy After CABG, Shows No Benefit Over Aspirin Alone

Shorter Dual Antiplatelet Therapy Shows Promise in Heart Attack Patients: Two Major Trials Challenge Current Guidelines

Single Antiplatelet Therapy Shows Superior Safety Profile Over Dual Therapy After TAVR